T. Rowe Price Associates’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
+21,909
| New | +$125K | ﹤0.01% | 2848 |
|
|
2021
Q4 | – | Sell |
-976
| Closed | -$27K | – | 2971 |
|
|
2021
Q3 | $27K | Buy |
+976
| New | +$27K | ﹤0.01% | 2918 |
|
|
2019
Q2 | – | Sell |
-100,134
| Closed | -$18.4M | – | 2534 |
|
|
2019
Q1 | $18.4M | Sell |
100,134
-1,848
| -2% | -$340K | ﹤0.01% | 1197 |
|
|
2018
Q4 | $18.2M | Sell |
101,982
-39,239
| -28% | -$7M | ﹤0.01% | 1172 |
|
|
2018
Q3 | $45.2M | Sell |
141,221
-8,763
| -6% | -$2.8M | 0.01% | 951 |
|
|
2018
Q2 | $60M | Buy |
149,984
+96,537
| +181% | +$38.6M | 0.01% | 823 |
|
|
2018
Q1 | $19.2M | Buy |
53,447
+24,077
| +82% | +$8.64M | ﹤0.01% | 1197 |
|
|
2017
Q4 | $11.6M | Buy |
29,370
+21,011
| +251% | +$8.33M | ﹤0.01% | 1299 |
|
|
2017
Q3 | $3.56M | Buy |
+8,359
| New | +$3.56M | ﹤0.01% | 1462 |
|